AKTX

Akari Therapeutics (AKTX)

About Akari Therapeutics (AKTX)

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Details

Daily high

$6.58

Daily low

$6.13

Price at open

$6.54

52 Week High

$56.80

52 Week Low

$3.25

Market cap

282.9M

Dividend yield

0.00%

Volume

4,281

Avg. volume

54,756

P/E ratio

-.02

Akari Therapeutics News